PH20353A - (1h-tetrazal-5-yl) tetrazolo 1,5-a quinolines and method of use thereof - Google Patents

(1h-tetrazal-5-yl) tetrazolo 1,5-a quinolines and method of use thereof

Info

Publication number
PH20353A
PH20353A PH30426A PH30426A PH20353A PH 20353 A PH20353 A PH 20353A PH 30426 A PH30426 A PH 30426A PH 30426 A PH30426 A PH 30426A PH 20353 A PH20353 A PH 20353A
Authority
PH
Philippines
Prior art keywords
tetrazolo
quinolines
tetrazal
compounds
azide
Prior art date
Application number
PH30426A
Other languages
English (en)
Inventor
Terry L Wright
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PH20353A publication Critical patent/PH20353A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
PH30426A 1983-03-25 1984-03-22 (1h-tetrazal-5-yl) tetrazolo 1,5-a quinolines and method of use thereof PH20353A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/478,964 US4496569A (en) 1983-03-25 1983-03-25 Antiallergic (1H-tetrazol-5-yl)tetrazolo[1,5-a]quinolines and derivatives thereof

Publications (1)

Publication Number Publication Date
PH20353A true PH20353A (en) 1986-12-04

Family

ID=23902115

Family Applications (1)

Application Number Title Priority Date Filing Date
PH30426A PH20353A (en) 1983-03-25 1984-03-22 (1h-tetrazal-5-yl) tetrazolo 1,5-a quinolines and method of use thereof

Country Status (19)

Country Link
US (1) US4496569A (de)
EP (1) EP0120484B1 (de)
JP (1) JPS59176287A (de)
KR (1) KR900003649B1 (de)
AT (1) ATE26717T1 (de)
AU (1) AU558762B2 (de)
CA (1) CA1252100A (de)
DE (1) DE3463271D1 (de)
DK (1) DK165694C (de)
ES (1) ES8601970A1 (de)
GR (1) GR81463B (de)
IE (1) IE57072B1 (de)
IL (1) IL71318A (de)
MX (1) MX9203341A (de)
NO (1) NO161067C (de)
NZ (1) NZ207582A (de)
PH (1) PH20353A (de)
PT (1) PT78288B (de)
ZA (1) ZA842067B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014171A1 (de) * 1990-05-03 1991-11-07 Basf Ag Cyanochinolinverbindungen
CN1043644C (zh) * 1994-03-25 1999-06-16 默里尔药物公司 制备(1H-四唑-5-基)四唑并[1,5-a]喹啉和1,8-二氮杂萘的方法
JP3674407B2 (ja) 1999-09-21 2005-07-20 ヤマハ株式会社 演奏データ編集装置、方法及び記録媒体
JP2007506788A (ja) * 2003-09-26 2007-03-22 ライジェル ファーマシューティカルズ, インコーポレイテッド Hcv感染阻害剤とその使用法
WO2005121138A2 (en) * 2004-06-03 2005-12-22 Rigel Pharmaceuticals, Inc. Heterotricyclic compounds for use as hcv inhibitors
KR101101950B1 (ko) * 2011-11-04 2012-01-02 이동진 왕복 페달식 자전거

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764681A (en) * 1970-07-08 1973-10-09 Lilly Co Eli Certain tetrazolo-(1,5-a) quinoline compounds as fungus control agents
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds

Also Published As

Publication number Publication date
IE57072B1 (en) 1992-04-22
ES530876A0 (es) 1985-11-01
NZ207582A (en) 1986-10-08
ZA842067B (en) 1984-10-31
DK165694C (da) 1993-06-07
US4496569A (en) 1985-01-29
EP0120484B1 (de) 1987-04-22
PT78288A (en) 1984-04-01
EP0120484A1 (de) 1984-10-03
KR900003649B1 (ko) 1990-05-28
ATE26717T1 (de) 1987-05-15
NO161067C (no) 1989-06-28
NO161067B (no) 1989-03-20
MX9203341A (es) 1992-08-01
AU558762B2 (en) 1987-02-05
DK165584A (da) 1984-09-26
IL71318A (en) 1986-11-30
KR840008156A (ko) 1984-12-13
DK165694B (da) 1993-01-04
GR81463B (de) 1984-12-11
JPS59176287A (ja) 1984-10-05
PT78288B (en) 1986-04-22
DE3463271D1 (en) 1987-05-27
JPH0415791B2 (de) 1992-03-19
CA1252100A (en) 1989-04-04
NO841156L (no) 1984-09-26
AU2595384A (en) 1984-09-27
DK165584D0 (da) 1984-03-23
IL71318A0 (en) 1984-06-29
ES8601970A1 (es) 1985-11-01
IE840719L (en) 1984-09-25

Similar Documents

Publication Publication Date Title
AU2587384A (en) Benzimidazole or imidazo (4,5-6) pyrioine derivatives
DE3868308D1 (de) Heterozyklische derivate, verfahren zu deren herstellung und diese enthaltende radiosensibilisierende agenzien und antivirale agenzien.
EP0124314A3 (de) Substituierte-3H-Indeno(1,2-c)pyridazin-3one
ZA841603B (en) Triazolo(4,3-c)pyrimidines and triazolo(1,5-c)pyrimidines substituted by nitrogen-containing heterocyclic rings
PT78289A (en) (1h-tetrazol-5-yl)2(1h)-quinolines and related compounds
DE3463271D1 (en) (1h-tetrazol-5-yl)tetrazolo (1,5-a)-quinolines and related compounds
IE831145L (en) Pyridine derivatives
NO962243D0 (no) Halogenarylsubstituerte metallkomplekser, farmasöytiske midler inneholdende slike og deres anvendelse i diagnostikken, samt fremgangsmåte for fremstilling av slike komplekser og midler
EP0274524A4 (de) Pyridon-pyridyl-imidazolyl- und triazolyl-verbindungen und deren verwendung als kardiotonische mittel.
DE3568432D1 (de) Tetrazolothienopyridines
EP0311634A4 (de) 6-(6-alkylpyridon)-carbostyril-verbindungen und deren kardiotonische verwendungen.
ZW3584A1 (en) New five-membered nitrogen-containing heterocyclic compounds processes for their preparation and their use as pest-combating agents
DE3478437D1 (en) Pyrazolo(1,5-a)pyridine derivatives and compositions containing them
DE3475193D1 (en) Triazolo(4,3-c)pyrimidines and triazolo(1,5-c)pyrimidines substituted by nitrogen-containing heterocyclic rings
ES8505357A1 (es) Un procedimiento para la preparacion de derivados de carboxi-tiazolo (3,2-a) pirimidina nuevos
DK33684D0 (da) Pyrazino (2',3'-3,4)pyrido(1,2-a)-indol-derivater
ATE50449T1 (de) (tetrazolyl)thienopyridone.
AU9107682A (en) 3,7alpha-diazacyclohepta(j,k)fluoriene derivatives
ZA84482B (en) Agent for separating dissolved and/or undissolved materials
ES8801215A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzazepina